Literature DB >> 18814259

Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria.

Shuo Shen1, Geetha Mahadevappa, Hsueh-Ling Janice Oh, Boon Yu Wee, Yook-Wah Choi, Le-Ann Hwang, Seng Gee Lim, Wanjin Hong, Sunil K Lal, Yee-Joo Tan.   

Abstract

The hemagglutinin (HA) of influenza A virus plays an essential role in mediating the entry of the virus into host cells. Here, recombinant full-length HA5 protein from a H5N1 isolate (A/chicken/hatay/2004(H5N1)) was expressed and purified from the baculovirus-insect cell system. As expected, full-length HA5 elicits strong neutralizing antibodies, as evaluated in micro-neutralization tests using HA5 pseudotyped lentiviral particles. In addition, two fragments of HA5 were expressed in bacteria and the N-terminal fragment, covering the ectodomain before the HA1/HA2 polybasic cleavage site, was found to elicit neutralizing antibodies. But the C-terminal fragment, which covers the remaining portion of the ectodomain, did not. Neutralizing titer of the anti-serum against the N-terminal fragment is only four times lower than the anti-serum against the full-length HA5 protein. Using a novel membrane fusion assay, the abilities of these antibodies to block membrane fusion were found to correlate well with the neutralization activities. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18814259     DOI: 10.1002/jmv.21298

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Authors:  Hsueh-Ling Janice Oh; Sara Akerström; Shuo Shen; Sándor Bereczky; Helen Karlberg; Jonas Klingström; Sunil K Lal; Ali Mirazimi; Yee-Joo Tan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus.

Authors:  Pei-Feng Liu; Yanhan Wang; Yu-Tsueng Liu; Chun-Ming Huang
Journal:  J Nat Sci       Date:  2017-02

3.  Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Authors:  Felix W Santiago; Kris Lambert Emo; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2012-05-15       Impact factor: 3.641

4.  Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.

Authors:  Surender Khurana; Swati Verma; Nitin Verma; Corey J Crevar; Donald M Carter; Jody Manischewitz; Lisa R King; Ted M Ross; Hana Golding
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

5.  Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes.

Authors:  Matthias Mueller; Sandra Renzullo; Roxann Brooks; Nicolas Ruggli; Martin A Hofmann
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus.

Authors:  Surender Khurana; Swati Verma; Nitin Verma; Corey J Crevar; Donald M Carter; Jody Manischewitz; Lisa R King; Ted M Ross; Hana Golding
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

7.  An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli.

Authors:  José M Aguilar-Yáñez; Roberto Portillo-Lara; Gonzalo I Mendoza-Ochoa; Sergio A García-Echauri; Felipe López-Pacheco; David Bulnes-Abundis; Johari Salgado-Gallegos; Itzel M Lara-Mayorga; Yenny Webb-Vargas; Felipe O León-Angel; Ramón E Rivero-Aranda; Yuriana Oropeza-Almazán; Guillermo M Ruiz-Palacios; Manuel I Zertuche-Guerra; Rebecca M DuBois; Stephen W White; Stacey Schultz-Cherry; Charles J Russell; Mario M Alvarez
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.

Authors:  Zuzana Biesova; Mark A Miller; Rachel Schneerson; Joseph Shiloach; Kim Y Green; John B Robbins; Jerry M Keith
Journal:  Vaccine       Date:  2009-08-15       Impact factor: 3.641

9.  A nonfusogenic antigen mimic of influenza hemagglutinin glycoproteins constituted with soluble full-length HA1 and truncated HA2 proteins expressed in E. coli.

Authors:  Chang Sup Kim; Youn-Je Park
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

10.  Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris.

Authors:  T N Athmaram; Shweta Saraswat; Anil Kumar Singh; M Kameswara Rao; N Gopalan; V V S Suryanarayana; P V L Rao
Journal:  Virus Genes       Date:  2012-09-02       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.